Organogenesis Holdings (ORGO)

• Market cap: $539M
• 1 day: 0.47%
• 5 days: -0.93%
• 1 month: 0.71%
• 3 months: -8.01%
• 6 months: -13.44%
• Year to date: 40.26%
• 1 year: 53.43%
• 5 years: 15.8%
• 10 years: -56.41%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Employees: 869